Triterpene derivatives for the treatment of cancer and inflammatory disease by inhibition of NF-κB
US7795306B2 · kind B2 · utility
3Cited by
8References
3Claims
0Family size
Inventors
Key dates
| Filing date | Mar 1, 2007 |
| Grant date | Sep 14, 2010 |
| Priority date | — |
| Expiry date | Mar 1, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of triterpenes of the formula (I): which are inhibitors of nuclear factor kappa B (NF-κB for use in the treatment of inflammatory diseases and for cancers susceptible to an NF-κB inhibitor. The present invention also relates to compounds and methods useful to inhibit cell proliferation and for the induction of apoptosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.